Entero Therapeutics (ENTO) announced that the board of directors has appointed Richard Paolone as the interim CEO of the company. Richard Paolone is a Toronto-based securities lawyer with extensive experience in corporate finance, securities law, and mergers and acquisitions.
Education
About Us
Working with TipRanks
Follow Us
1